A. Felner

Cumulative effects of irreversible MAO inhibitors in vivo.

P. Waldmeier, A. Felner, 1979, Biochemical pharmacology.

The effects of 5-HT uptake- and MAO-inhibitors on l-5-HTP-induced excitation in rats

A. Delini-Stula, P. Waldmeier, R. Ortmann, 1980, Naunyn-Schmiedeberg's Archives of Pharmacology.

CGP 4718 A, a new potential antidepressant with a dual mode of action.

K. Tipton, P. Waldmeier, R. Bernasconi, 1984, European journal of pharmacology.

The monoamine oxidase inhibiting properties of CGP 11305 A.

K. Tipton, P. Waldmeier, A. Felner, 1983, European journal of pharmacology.

Phenylethylamine-induced stereotypies in the rat: a behavioral test system for assessment of MAO-B inhibitors

P. Waldmeier, R. Ortmann, M. Schaub, 2004, Psychopharmacology.

Monoamine oxidase inhibition in brain and liver of rats treated with chlordimeform.

P. Waldmeier, L. Maître, W. Kehr, 1978, Journal of agricultural and food chemistry.

Characterization of a new, short-acting and specific inhibitor of type A monoamine oxidase.

A. Delini-Stula, P. Waldmeier, R. Bernasconi, 1983, Modern problems of pharmacopsychiatry.

Deprenil: loss of selectivity for inhibition of B-type MAO after repeated treatment.

P. Waldmeier, A. Felner, 1978, Biochemical pharmacology.